연구성과로 돌아가기

2024 연구자 정보 (157 / 1079)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 ⓘ 교신저자 여부 ⓘ Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Choi, Jinsol
(Choi, J) ⓘ 		Keimyung Univ, Coll Pharm, Daegu 42601, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 5.3] Exploiting mechanoregulation via FAK/YAP to overcome platinum resistance in ovarian cancer ⓘ SCIE ⓘ 5.3 MEDICINE, RESEARCH & EXPERIMENTAL;PHARMACOLOGY & PHARMACY ⓘ sypark20@kmu.ac.kr; ⓘ
Dang, Loi Nguyen
(Dang, LN) ⓘ 		제1저자 Keimyung Univ, Coll Pharm, Daegu 42601, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 5.3] Exploiting mechanoregulation via FAK/YAP to overcome platinum resistance in ovarian cancer ⓘ SCIE ⓘ 5.3 MEDICINE, RESEARCH & EXPERIMENTAL;PHARMACOLOGY & PHARMACY ⓘ sypark20@kmu.ac.kr; ⓘ
Ghosh, Avijit
(Ghosh, A) ⓘ 		Univ Calcutta, Ctr Res Nanosci & Nanotechnol, Technol Campus,Salt Lake, Kolkata 700106, West Bengal, India ⓘ JMN-2589-2023
Ghosh, Avijit ⓘ
ⓘ 		[JCR상위 5.3] Nanocarrier mediated co-delivery of phytochemicals and chemo-drugs: an emerging strategy to combat lung cancer in a systemic way ⓘ SCIE ⓘ 5.3 PLANT SCIENCES ⓘ debraj.thoudam@gmail.com; ⓘ
Han, Sang-Bae
(Han, SB) ⓘ 		교신저자 Chungbuk Natl Univ, Coll Pharm, 194-21 Osongsaengmyeong 1 Ro, Cheongju 28160, Chungbuk, South Korea
Chungbuk Natl Univ, Med Res Ctr, 194-21 Osongsaengmyeong 1 Ro, Cheongju 19431, Chungbuk, South Korea
Chungbuk Natl Univ, Coll Pharm, 194-31 Osongsaengmyeong 1 Ro, Cheongju 28160, Chungbuk, South Korea
Chungbuk Natl Univ, Med Res Ctr, 194-31 Osongsaengmyeong 1 Ro, Cheongju 28160, Chungbuk, South Korea
Chungbuk Natl Univ, Coll Pharm & Med Res Ctr, Osongsaengmyeong 1 ro,Osong eup, Cheongju 28160, Chungbuk, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 5.3] TNF receptor 2 knockout mouse had reduced lung cancer growth and schizophrenia-like behavior through a decrease in TrkB-dependent BDNF level
[JCR상위 3.8] Significance of chitinase-3-like protein 1 in the pathogenesis of inflammatory diseases and cancer
[JCR상위 5.0] Anti-chitinase-3-like 1 antibody attenuated atopic dermatitis-like skin inflammation through inhibition of STAT3-dependent CXCL8 expression ⓘ 		SCIE ⓘ 3.8 CHEMISTRY, MEDICINAL;PHARMACOLOGY & PHARMACY
BIOCHEMISTRY & MOLECULAR BIOLOGY;MEDICINE, RESEARCH & EXPERIMENTAL
PHARMACOLOGY & PHARMACY ⓘ 		shan@chungbuk.ac.kr;jinthong@chungbuk.ac.kr;
sondj@chungbuk.ac.kr;jinthong@chungbuk.ac.kr;
kallintz@gmali.com;jinthong@chungbuk.ac.kr; ⓘ
Hong, Jin Tae
(Hong, JT) ⓘ 		교신저자 Chungbuk Natl Univ, Coll Pharm, 194-21 Osongsaengmyeong 1 Ro, Cheongju 28160, Chungbuk, South Korea
Chungbuk Natl Univ, Med Res Ctr, 194-21 Osongsaengmyeong 1 Ro, Cheongju 19431, Chungbuk, South Korea
Chungbuk Natl Univ, Coll Pharm, 194-31 Osongsaengmyeong 1 Ro, Cheongju 28160, Chungbuk, South Korea
Chungbuk Natl Univ, Med Res Ctr, 194-31 Osongsaengmyeong 1 Ro, Cheongju 28160, Chungbuk, South Korea
Chungbuk Natl Univ, Coll Pharm & Med Res Ctr, Osongsaengmyeong 1 ro,Osong eup, Cheongju 28160, Chungbuk, South Korea ⓘ
ⓘ 		0000-0002-6534-9575
Hong, Jin Tae ⓘ 		[JCR상위 5.3] TNF receptor 2 knockout mouse had reduced lung cancer growth and schizophrenia-like behavior through a decrease in TrkB-dependent BDNF level
[JCR상위 3.8] Significance of chitinase-3-like protein 1 in the pathogenesis of inflammatory diseases and cancer
[JCR상위 5.0] Anti-chitinase-3-like 1 antibody attenuated atopic dermatitis-like skin inflammation through inhibition of STAT3-dependent CXCL8 expression ⓘ 		SCIE ⓘ 3.8 CHEMISTRY, MEDICINAL;PHARMACOLOGY & PHARMACY
BIOCHEMISTRY & MOLECULAR BIOLOGY;MEDICINE, RESEARCH & EXPERIMENTAL
PHARMACOLOGY & PHARMACY ⓘ 		shan@chungbuk.ac.kr;jinthong@chungbuk.ac.kr;
sondj@chungbuk.ac.kr;jinthong@chungbuk.ac.kr;
kallintz@gmali.com;jinthong@chungbuk.ac.kr; ⓘ
Jang, Se Hyeon
(Jang, SH) ⓘ 		Kyungpook Natl Univ, Sch Food Sci & Biotechnol, Daegu 41566, South Korea ⓘ AAO-6009-2020
Jang, Hyeon ⓘ
ⓘ 		[JCR상위 5.3] Hybrid nutraceutical of 2-ketoglutaric acid in improving inflammatory bowel disease: Role of prebiotics and TAK1 inhibitor ⓘ SCIE ⓘ 5.3 MEDICINE, RESEARCH & EXPERIMENTAL;PHARMACOLOGY & PHARMACY ⓘ skjung04@knu.ac.kr; ⓘ
Jo, Miran
(Jo, M) ⓘ 		Chungbuk Natl Univ, Coll Pharm, 194-21 Osongsaengmyeong 1 Ro, Cheongju 28160, Chungbuk, South Korea
Chungbuk Natl Univ, Med Res Ctr, 194-21 Osongsaengmyeong 1 Ro, Cheongju 19431, Chungbuk, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 5.3] TNF receptor 2 knockout mouse had reduced lung cancer growth and schizophrenia-like behavior through a decrease in TrkB-dependent BDNF level ⓘ SCIE ⓘ 5.3 CHEMISTRY, MEDICINAL;PHARMACOLOGY & PHARMACY ⓘ shan@chungbuk.ac.kr;jinthong@chungbuk.ac.kr; ⓘ
Kang, Han Chang
(Kang, HC) ⓘ 		Catholic Univ Korea, Coll Pharm, Bucheon 14662, South Korea
Catholic Univ Korea, BK21 Four Sponsored Adv Program SmartPharma Leader, Bucheon 14662, South Korea ⓘ 		I-5999-2019
Kang, Han ⓘ
ⓘ 		[JCR상위 5.3] Comparative metabolism of aschantin in human and animal hepatocytes ⓘ SCIE ⓘ 5.3 CHEMISTRY, MEDICINAL;PHARMACOLOGY & PHARMACY ⓘ sianalee@catholic.ac.kr; ⓘ
Kim, Joo Seong
(Kim, JS) ⓘ 		Dongguk Univ, Med Ctr, Dept Internal Med, Coll Med, Goyang, South Korea ⓘ J-5425-2012
Kim, Ik-Sang ⓘ
ⓘ 		[JCR상위 5.3] Side-by-side placement of fully covered metal stents versus conventional 7F plastic stents in malignant hilar biliary obstruction: Prospective randomized controlled trial ⓘ SCIE ⓘ 5.3 GASTROENTEROLOGY & HEPATOLOGY;SURGERY ⓘ gidoctor@snu.ac.kr; ⓘ
Kim, San
(Kim, S) ⓘ 		제1저자 Kyungpook Natl Univ, Sch Food Sci & Biotechnol, Daegu 41566, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 5.3] Hybrid nutraceutical of 2-ketoglutaric acid in improving inflammatory bowel disease: Role of prebiotics and TAK1 inhibitor
[JCR상위 52.8] Curcuma longa L. extract increased immune responses in RAW 264.7 cells and cyclophosphamide-induced BALB/c mice
[JCR상위 44.4] Innate Immune-Enhancing Effect of Pinus densiflora Pollen Extract via NF-κB Pathway Activation ⓘ 		SCIE ⓘ 5.3 MEDICINE, RESEARCH & EXPERIMENTAL;PHARMACOLOGY & PHARMACY
FOOD SCIENCE & TECHNOLOGY
MICROBIOLOGY;BIOTECHNOLOGY & APPLIED MICROBIOLOGY ⓘ 		skjung04@knu.ac.kr;
sryoon@korea.kr;skjung04@knu.ac.kr; ⓘ
Kim, Sung-Hyun
(Kim, SH) ⓘ 		Chungbuk Natl Univ, Coll Pharm, 194-21 Osongsaengmyeong 1 Ro, Cheongju 28160, Chungbuk, South Korea
Chungbuk Natl Univ, Med Res Ctr, 194-21 Osongsaengmyeong 1 Ro, Cheongju 19431, Chungbuk, South Korea
Dong A Univ, Coll Med, Dept Hematol Oncol, Busan, South Korea
Dong A Univ, Coll Med, Dept Internal Med, Div Hematol Oncol, Busan, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 5.3] TNF receptor 2 knockout mouse had reduced lung cancer growth and schizophrenia-like behavior through a decrease in TrkB-dependent BDNF level
[JCR상위 18.1] Validation of the 2022 European LeukemiaNet risk stratification for acute myeloid leukemia
[JCR상위 10.7] Superior outcomes and high-risk features with carfilzomib, lenalidomide, and dexamethasone combination therapy for patients with relapsed and refractory multiple myeloma: results of the multicenter KMMWP2201 study ⓘ 		SCIE ⓘ 5.3 CHEMISTRY, MEDICINAL;PHARMACOLOGY & PHARMACY
MULTIDISCIPLINARY SCIENCES
HEMATOLOGY ⓘ 		shan@chungbuk.ac.kr;jinthong@chungbuk.ac.kr;
f0115@chonnam.ac.kr;dr.dennis.kim@uhn.ca;
kshmoon@dau.ac.kr;kihyunkimk@gmail.com; ⓘ
Kim, Young Hoon
(Kim, YH) ⓘ 		Seoul Natl Univ, Inst Agr & Life Sci, Dept Agr Biotechnol & Res, Seoul 08826, South Korea
Asan Med Ctr, Dept Surg, Div Kidney Transplantat, Seoul, South Korea
Univ Ulsan, Coll Med, Seoul, South Korea ⓘ 		F-5424-2012
E-5614-2012
Kim, Young Hoon
Kim, Young-Hoon ⓘ
ⓘ 		[JCR상위 5.3] Hybrid nutraceutical of 2-ketoglutaric acid in improving inflammatory bowel disease: Role of prebiotics and TAK1 inhibitor
[JCR상위 8.6] Cardioprotective Effect of SGLT2 Inhibitor in Diabetic Kidney Transplant Recipients: A Multicenter Propensity Score Matched Study ⓘ 		SCIE ⓘ 5.3 MEDICINE, RESEARCH & EXPERIMENTAL;PHARMACOLOGY & PHARMACY
UROLOGY & NEPHROLOGY ⓘ 		skjung04@knu.ac.kr;
jh-cho@knu.ac.kr; ⓘ
Lee, Eunhee
(Lee, EH) ⓘ 		Keimyung Univ, Coll Pharm, Daegu 42601, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 5.3] Exploiting mechanoregulation via FAK/YAP to overcome platinum resistance in ovarian cancer ⓘ SCIE ⓘ 5.3 MEDICINE, RESEARCH & EXPERIMENTAL;PHARMACOLOGY & PHARMACY ⓘ sypark20@kmu.ac.kr; ⓘ
Lee, Hye Suk
(Lee, HS) ⓘ 		교신저자 Catholic Univ Korea, Coll Pharm, Bucheon 14662, South Korea
Catholic Univ Korea, BK21 Four Sponsored Adv Program SmartPharma Leader, Bucheon 14662, South Korea
Catholic Univ Korea, Sponsored Adv Program Smart Pharma Leaders BK21 44, Bucheon 14662, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 5.3] Comparative metabolism of aschantin in human and animal hepatocytes
[JCR상위 9.5] In Vitro Metabolism and Transport Characteristics of Zastaprazan ⓘ 		SCIE ⓘ 5.3 CHEMISTRY, MEDICINAL;PHARMACOLOGY & PHARMACY
PHARMACOLOGY & PHARMACY ⓘ 		sianalee@catholic.ac.kr;
minseo.lee@catholic.ac.kr;legadema0905@knu.ac.kr;mignon@dankook.ac.kr;john.kim@onconic.co.kr;hj.cha@onconic.co.kr;bycheon@onconic.co.kr;minkoochoi@dankook.ac.kr;isssong@knu.ac.kr;sianalee@catholic.ac.kr; ⓘ
Lee, Jeong Jae
(Lee, JJ) ⓘ 		Kyungpook Natl Univ, Sch Food Sci & Biotechnol, Daegu 41566, South Korea
Kyungpook Natl Univ, Inst Agr Sci & Technol, Daegu, South Korea
Kyungpook Natl Univ, Inst Agr Sci & Technol, Daegu 41566, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 5.3] Hybrid nutraceutical of 2-ketoglutaric acid in improving inflammatory bowel disease: Role of prebiotics and TAK1 inhibitor
Dietary supplementation with probiotics promotes weight loss by reshaping the gut microbiome and energy metabolism in obese dogs
[JCR상위 44.4] Change in the Gut Microbiota of Lactating Sows and Their Piglets by Inclusion of-Dried Plasma in Sow Diets ⓘ 		SCIE ⓘ 5.3 MEDICINE, RESEARCH & EXPERIMENTAL;PHARMACOLOGY & PHARMACY
MICROBIOLOGY;BIOTECHNOLOGY & APPLIED MICROBIOLOGY ⓘ 		skjung04@knu.ac.kr;
osangnam@jj.ac.kr;ykeys2584@snu.ac.kr;
hbkim@dankook.ac.kr;mhsong@cnu.ac.kr; ⓘ
페이지 이동: